Perspective Therapeutics Inc (CATX)
R&D to Revenue
26597.53%
Quarterly · Period ending:
CATX R&D to Revenue
Latest reported26597.53%period ending
Latest reported26597.53%period ending
CATX Quarterly R&D/Revenue (0.00% → 26597.53%)
Latest values, visible window
High-resolution chart · PNG
CATX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |